Log in

Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study

  • Original Article
  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

The present study was designed to determine the applicability of a newly derived dimensionless number precipitation parameter, “supersaturation holding capacity (SHC)” in development of amorphous solid dispersion (ASD) of a rapidly crystallizing drug, nisoldipine. Also, ASD preparation from lab scale formulation technique to scalable spray drying technique followed by oral bioavailability study was demonstrated. Solution state screening of polymers was performed by determining nucleation induction time (tin) and SHC. With screened polymers, lab scale ASDs of nisoldipine were prepared using rotary evaporation (solvent evaporation) method, and the optimized stable ASDs were scaled up by spray drying. The ASDs were characterized by DSC, PXRD, and FTIR for amorphous nature and evaluated for apparent solubility, dissolution, and solid-state stability improvement. The spray dried ASDs were additionally evaluated for micrometric properties and oral bioavailability study.PVP grades demonstrated superior crystal growth inhibition properties (with 2–4-fold enhancements in SHC). ASDs prepared by both lab scale and scale-up technique using PVP stabilized the amorphous nisoldipine via antiplasticization effect that maintained the stability under accelerated stability conditions (40 °C/75% RH) for 6 months. Additionally, FTIR study confirmed the role of intermolecular interactions in amorphous state stabilization of PVP-based solid dispersions. PVP-based spray dried ASDs improved the apparent solubility 4-fold for PVP K17 and more than 3-fold for remaining spray dried ASDs. The enhanced solubility was translated to improved dissolution of the drug when compared with crystalline and amorphous form complementing the outcome of the solution state study. The spray dried ASD showed 2.3 and > 3-fold the improvement in Cmax and AUC (0–24 h) respectively when compared with crystalline nisoldipine during oral bioavailability study which highlights the significance of SHC parameter of polymers. The spray dried ASD has shown improved micromeritics properties then crystalline nisoldipine in terms of flow behavior.This unique study provides a rational strategy for selection of appropriate polymer in development of ASDs that can tackle both precipitation during dissolution and amorphous state stabilization in solid state and also considers the SHC in scale-up study.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Kini A, Patel SB. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat. Pharm Dev Technol. 2017;22(1):45–57.

    Article  CAS  PubMed  Google Scholar 

  2. Chauhan H, Kuldipkumar A, Barder T, Medek A, Gu CH, Atef E. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction. Pharm Res. 2014;31(2):500–15.

    Article  CAS  PubMed  Google Scholar 

  3. Kaushal AM, Gupta P, Bansal AK. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst. 2004;21(3):133–93.

    Article  CAS  PubMed  Google Scholar 

  4. Price D, Ditzinger F, Koehl N, Jankovic S, Tsakiridou G, Nair A, et al. Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations–a PEARRL review. J Pharm Pharmacol. 2019;71(4):483–509.

    Article  CAS  PubMed  Google Scholar 

  5. Chavan RB, Rathi S, Jyothi VGS, Shastri NR. Cellulose based polymers in development of amorphous solid dispersions. Asian J Pharm Sci. 2019;14(3):248–64.

    Article  PubMed  Google Scholar 

  6. Mahmah O, Tabbakh R, Kelly A, Paradkar A. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine. J Pharm Pharmacol. 2014;66(2):275–84.

    Article  CAS  PubMed  Google Scholar 

  7. Chauhan H, Hui Gu C, Atef E. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions. J Pharm Sci. 2013;102(6):1924–35.

    Article  CAS  PubMed  Google Scholar 

  8. Brough C, Williams R. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Int J Pharm. 2013;453(1):157–66.

    Article  CAS  PubMed  Google Scholar 

  9. Qian F, Huang J, Hussain MA. Drug–polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development. J Pharm Sci. 2010;99(7):2941–7.

    Article  CAS  PubMed  Google Scholar 

  10. Tran P, Pyo YC, Kim DH, Lee SE, Kim JK, Park JS. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 2019;11(3):132.

    Article  CAS  PubMed Central  Google Scholar 

  11. Price DJ, Ditzinger F, Koehl NJ, Jankovic S, Tsakiridou G, Nair A, et al. Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations–a PEARRL review. J Pharm Pharmacol. 2019;71(4):483–509.

    Article  CAS  PubMed  Google Scholar 

  12. Miao L, Liang Y, Pan W, Gou J, Yin T, Zhang Y, et al. Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion. Drug Deliv Transl Res. 2019;9(1):344–56.

    Article  CAS  PubMed  Google Scholar 

  13. Alonzo DE, Zhang GG, Zhou D, Gao Y, Taylor LS. Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res. 2010;27(4):608–18.

    Article  CAS  PubMed  Google Scholar 

  14. Ilevbare GA, Liu H, Edgar KJ, Taylor LS. Maintaining supersaturation in aqueous drug solutions: impact of different polymers on induction times. Cryst Growth Des. 2012;13(2):740–51.

    Article  CAS  Google Scholar 

  15. Chavan RB, Thipparaboina R, Kumar D, Shastri NR. Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth. RSC Adv. 2016;6(81):77569–76.

    Article  CAS  Google Scholar 

  16. Alonzo DE, Raina S, Zhou D, Gao Y, Zhang GG, Taylor LS. Characterizing the impact of hydroxypropylmethyl cellulose on the growth and nucleation kinetics of felodipine from supersaturated solutions. Cryst Growth Des. 2012;12(3):1538–47.

    Article  CAS  Google Scholar 

  17. Ilevbare GA, Liu H, Edgar KJ, Taylor LS. Understanding polymer properties important for crystal growth inhibition impact of chemically diverse polymers on solution crystal growth of ritonavir. Cryst Growth Des. 2012;12(6):3133–43.

    Article  CAS  Google Scholar 

  18. Ilevbare GA, Liu H, Edgar KJ, Taylor LS. Inhibition of solution crystal growth of ritonavir by cellulose polymers–factors influencing polymer effectiveness. CrystEngComm. 2012;14(20):6503–14.

    Article  CAS  Google Scholar 

  19. Chavan RB, Lodagekar A, Shastri NR. Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions. Drug Dev Ind Pharm. 2018;44(12):1933–41.

    Article  CAS  PubMed  Google Scholar 

  20. Rathi S, Chavan RB, Shastri NR. Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state. Drug Deliv Transl Res. 2020;10(1):70–82 1–13.

    Article  PubMed  Google Scholar 

  21. Chopra S, Venkatesan N, Betageri GV. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs. Int J Pharm. 2013;446(1):136–44.

    Article  CAS  PubMed  Google Scholar 

  22. Fu Q, Fang M, Hou Y, Yang W, Shao J, Guo M, et al. A physically stabilized amorphous solid dispersion of nisoldipine obtained by hot melt extrusion. Powder Technol. 2016;301:342–8.

    Article  CAS  Google Scholar 

  23. Zong L, **ao Y, Chen L. Studies on improvement of dissolution and modification of dissolution rate of nisoldipine with binary solid dispersion [J]. Chin Pharm J. 2005;3:013.

    Google Scholar 

  24. Gupta P, Chawla G, Bansal AK. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility. Mol Pharm. 2004;1(6):406–13.

    Article  CAS  PubMed  Google Scholar 

  25. Lee H, Blaufox M. Blood volume in the rat. J Nucl Med. 1985;26(1):72–6.

    CAS  PubMed  Google Scholar 

  26. Stypinski D, Wiebe L, Tam Y, Mercer J, McEwan A. Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague–Dawley rats. Nucl Med Biol. 1999;26(8):959–65.

    Article  CAS  PubMed  Google Scholar 

  27. Guzman HR, Tawa M, Zhang Z, Ratanabanangkoon P, Shaw P, Gardner CR, et al. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. J Pharm Sci. 2007;96(10):2686–702.

    Article  CAS  PubMed  Google Scholar 

  28. Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm. 1999;181(2):143–51.

    Article  CAS  PubMed  Google Scholar 

  29. Baghel S, Cathcart H, O'Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016;105(9):2527–44.

    Article  CAS  PubMed  Google Scholar 

  30. Gupta P, Bansal AK. Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine. Pharm Dev Technol. 2005;10(2):273–81.

    Article  CAS  PubMed  Google Scholar 

  31. Davis M. Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs. J Control Release. 2017;269:110–27.

    Article  PubMed  CAS  Google Scholar 

  32. Ziaee A, Albadarin AB, Padrela L, Faucher A, O'reilly E, Walker G. Spray drying ternary amorphous solid dispersions of ibuprofen–an investigation into critical formulation and processing parameters. Eur J Pharm Biopharm. 2017;120:43–51.

    Article  CAS  PubMed  Google Scholar 

  33. Chamsai B, Limmatvapirat S, Sungthongjeen S, Sriamornsak P. Enhancement of solubility and oral bioavailability of manidipine by formation of ternary solid dispersion with d-α-tocopherol polyethylene glycol 1000 succinate and copovidone. Drug Dev Ind Pharm. 2017;43(12):2064–75.

    Article  CAS  PubMed  Google Scholar 

  34. Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98(8):2549–72.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors acknowledge the financial support from the Department of Pharmaceuticals (DoP), Ministry of Chemicals, and Fertilizers, Govt. of India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nalini R. Shastri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 2286 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chavan, R.B., Lodagekar, A., Yadav, B. et al. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study. Drug Deliv. and Transl. Res. 10, 903–918 (2020). https://doi.org/10.1007/s13346-020-00775-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-020-00775-8

Keywords

Navigation